Coronary Calcium Score and Cardiovascular Risk

Journal of the American College of Cardiology

Volumn 72, Issue 4, 2018, Pages 434-447

  Greenland, Philip ^a   Blaha, Michael J ^b   Budoff, Matthew J ^c   Erbel, Raimund ^d   Watson, Karol E ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LA BioMed ^*  (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aspirin; atherosclerotic cardiovascular disease; coronary artery calcification; coronary heart disease; statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ALL CAUSE MORTALITY; ASYMPTOMATIC DISEASE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; ETHNIC DIFFERENCE; HUMAN; INCIDENCE; INFLAMMATION; MORTALITY RISK; MYOCARDIAL PERFUSION IMAGING; OXIDATIVE STRESS; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; THORAX RADIOGRAPHY; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CORONARY BLOOD VESSEL; DISEASE MANAGEMENT; PATHOLOGY;

CARDIOVASCULAR DISEASES; CORONARY VESSELS; DISEASE MANAGEMENT; DISEASE PROGRESSION; HUMANS; RISK ASSESSMENT; VASCULAR CALCIFICATION;

EID: 85049732273     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.05.027     Document Type: Review

References (125)

1. Demer, L.L., Tintut, Y., Vascular calcification: pathobiology of a multifaceted disease. Circulation 117 (2008), 2938–2948.
2. Bild, D.E., Bluemke, D.A., Burke, G.L., et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 156 (2002), 871–881.
3. Hoffmann, U., Massaro, J.M., Fox, C.S., Manders, E., O'Donnell, C.J., Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol 102 (2008), 1136–1141.e1.
4. Schmermund, A., Möhlenkamp, S., Stang, A., et al., for the Heinz Nixdorf RECALL Study Investigative Group. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Am Heart J 144 (2002), 212–218.
5. Oei, H.H., Vliegenthart, R., Hak, A.E., et al. The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study. J Am Coll Cardiol 39 (2002), 1745–1751.
6. Agatston, A.S., Janowitz, W.R., Hildner, F.J., Zusmer, N.R., Viamonte, M. Jr., Detrano, R., Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990), 827–832.
7. Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. [Published correction appears in: J Am Coll Cardiol 2014;63:3026] J Am Coll Cardiol 63 (2014), 2935–2959.
8. Authors/Task Force Members, Piepoli, M.F., Hoes, A.W., et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol, 23, 2016 NP1-96.
9. van Kempen, B.J., Spronk, S., Koller, M.T., et al. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals. J Am Coll Cardiol 58 (2011), 1690–1701.
10. Pletcher, M.J., Pignone, M., Earnshaw, S., et al. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 7 (2014), 276–284.
11. Roberts, E.T., Horne, A., Martin, S.S., et al. Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA). PLoS ONE, 10, 2015, e0116377.
12. Galper, B.Z., Wang, Y.C., Einstein, A.J., Strategies for primary prevention of coronary heart disease based on risk stratification by the ACC/AHA lipid guidelines, ATP III guidelines, coronary calcium scoring, and C-reactive protein, and a global treat-all strategy: a comparative-effectiveness modeling study. PLoS ONE, 10, 2015, e0138092.
13. van Kempen, B.J., Ferket, B.S., Steyerberg, E.W., Max, W., Myriam Hunink, M.G., Fleischmann, K.E., Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population. Int J Cardiol 203 (2016), 422–431.
14. Hong, J.C., Blankstein, R., Shaw, L.J., et al. Implications of coronary artery calcium testing for treatment decisions among statin candidates according to the ACC/AHA cholesterol management guidelines: a cost-effectiveness analysis. J Am Coll Cardiol Img 10 (2017), 938–952.
15. Blue Cross Blue Shield CT Providers by State 2014. Available at: http://www.calciumscan.com/wp-content/uploads/2014/07/Blue-Cross-Blue-Shield-CTA-Providers.pdf Accessed May 24, 2018.
16. Tintut, Y., Alfonso, Z., Saini, T., et al. Multilineage potential of cells from the artery wall. Circulation 108 (2003), 2505–2510.
17. Tyson, K.L., Reynolds, J.L., McNair, R., Zhang, Q., Weissberg, P.L., Shanahan, C.M., Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23 (2003), 489–494.
18. Li, H., Hong, S., Qian, J., Zheng, Y., Yang, J., Yi, Q., Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 116 (2010), 210–217.
19. Tintut, Y., Parhami, F., Tsingotjidou, A., Tetradis, S., Territo, M., Demer, L.L., 8-Isoprostaglandin E2 enhances receptor-activated NFκB ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277 (2002), 14221–14226.
20. Bear, M., Butcher, M., Shaughnessy, S.G., Oxidized low-density lipoprotein acts synergistically with β-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells. J Cell Biochem 105 (2008), 185–193.
21. Tintut, Y., Morony, S., Demer, L.L., Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 24 (2004), e6–e10.
22. Chen, N.X., Duan, D., O'Neill, K.D., Moe, S.M., High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21 (2006), 3435–3442.
23. Wang, C.C., Sorribas, V., Sharma, G., Levi, M., Draznin, B., Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis 195 (2007), e65–e75.
24. Parhami, F., Tintut, Y., Ballard, A., Fogelman, A.M., Demer, L.L., Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88 (2001), 954–960.
25. Luo, X.H., Zhao, L.L., Yuan, L.Q., Wang, M., Xie, H., Liao, E.Y., Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res 24 (2009), 1461–1468.
26. Detrano, R., Markovic, D., Simpfendorfer, C., et al. Digital subtraction fluoroscopy: a new method of detecting coronary calcifications with improved sensitivity for the prediction of coronary disease. Circulation 71 (1985), 725–732.
27. Hamby, R.I., Tabrah, F., Wisoff, B.G., Hartstein, M.L., Coronary artery calcification: clinical implications and angiographic correlates. Am Heart J 87 (1974), 565–570.
28. Bartel, A.G., Chen, J.T., Peter, R.H., Behar, V.S., Kong, Y., Lester, R.G., The significance of coronary calcification detected by fluoroscopy. A report of 360 patients. Circulation 49 (1974), 1247–1253.
29. Rifkin, R.D., Parisi, A.F., Folland, E., Coronary calcification in the diagnosis of coronary artery disease. Am J Cardiol 44 (1979), 141–147.
30. Detrano, R., Salcedo, E.E., Hobbs, R.E., Yiannikas, J., Cardiac cinefluoroscopy as an inexpensive aid in the diagnosis of coronary artery disease. Am J Cardiol 57 (1986), 1041–1046.
31. Margolis, J.R., Chen, J.T., Kong, Y., Peter, R.H., Behar, V.S., Kisslo, J.A., The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology 137 (1980), 609–616.
32. Mao, S.S., Pal, R.S., McKay, C.R., et al. Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner. J Comput Assist Tomogr 33 (2009), 175–178.
33. Budoff, M.J., Nasir, K., Kinney, G.L., et al. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr 5 (2011), 113–118.
34. Shemesh, J., Henschke, C.I., Shaham, D., et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. [Published correction appears in Radiology 2011;259:617] Radiology 257 (2010), 541–548.
35. Simons, D.B., Schwartz, R.S., Edwards, W.D., Sheedy, P.F., Breen, J.F., Rumberger, J.A., Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol 20 (1992), 1118–1126.
36. Rumberger, J.A., Simons, D.B., Fitzpatrick, L.A., Sheedy, P.F., Schwartz, R.S., Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92 (1995), 2157–2162.
37. Rumberger, J.A., Schwartz, R.S., Simons, D.B., Sheedy, P.F. III, Edwards, W.D., Fitzpatrick, L.A., Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy. Am J Cardiol 73 (1994), 1169–1173.
38. Budoff, M.J., Diamond, G.A., Raggi, P., et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation 105 (2002), 1791–1796.
39. Shavelle, D.M., Budoff, M.J., LaMont, D.H., Shavelle, R.M., Kennedy, J.M., Brundage, B.H., Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol 36 (2000), 32–38.
40. Sangiorgi, G., Rumberger, J.A., Severson, A., et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31 (1998), 126–133.
41. Baumgart, D., Schmermund, A., Goerge, G., et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J Am Coll Cardiol 30 (1997), 57–64.
42. Greenland, P., LaBree, L., Azen, S.P., Doherty, T.M., Detrano, R.C., Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. [Published correction appears in JAMA 2004;291:563] JAMA 291 (2004), 210–215.
43. Arad, Y., Goodman, K.J., Roth, M., Newstein, D., Guerci, A.D., Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46 (2005), 158–165.
44. LaMonte, M.J., FitzGerald, S.J., Church, T.S., et al. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol 162 (2005), 421–429.
45. Raggi, P., Shaw, L.J., Berman, D.S., Callister, T.Q., Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43 (2004), 1663–1669.
46. McEvoy, J.W., Blaha, M.J., Rivera, J.J., et al. Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. J Am Coll Cardiol Img 5 (2012), 1037–1045.
47. Shaw, L.J., Raggi, P., Callister, T.Q., Berman, D.S., Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J 27 (2006), 968–975.
48. Raggi, P., Gongora, M.C., Gopal, A., Callister, T.Q., Budoff, M., Shaw, L.J., Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol 52 (2008), 17–23.
49. Tota-Maharaj, R., Blaha, M.J., McEvoy, J.W., et al. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J 33 (2012), 2955–2962.
50. Bild, D.E., Detrano, R., Peterson, D., et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111 (2005), 1313–1320.
51. McClelland, R.L., Chung, H., Detrano, R., Post, W., Kronmal, R.A., Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 113 (2006), 30–37.
52. Stang, A., Moebus, S., Dragano, N., et al., for the Heinz Nixdorf Recall Study Investigation Group. Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 20 (2005), 489–496.
53. Erbel, R., Möhlenkamp, S., Moebus, S., et al., for the Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 56 (2010), 1397–1406.
54. Lehmann, N., Erbel, R., Mahabadi, A.A., et al., for the Heinz Nixdorf Recall Study Investigators. Value of progression of coronary artery calcification for risk prediction of coronary and cardiovascular events: result of the HNR study (Heinz Nixdorf Recall). Circulation 137 (2018), 665–679.
55. Erbel, R., Delaney, J.A., Lehmann, N., et al., for the Multi-Ethnic Study of Atherosclerosis; Investigator Group of the Heinz Nixdorf Recall Study. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J 29 (2008), 2782–2791.
56. Hofman, A., Brusselle, G.G., Darwish Murad, S., et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 30 (2015), 661–708.
57. Vliegenthart, R., Oudkerk, M., Hofman, A., et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 112 (2005), 572–577.
58. Yano, Y., O'Donnell, C.J., Kuller, L., et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol 2 (2017), 986–994.
59. Kavousi, M., Desai, C.S., Ayers, C., et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA 316 (2016), 2126–2134.
60. Ferencik, M., Pencina, K.M., Liu, T., et al. Coronary artery calcium distribution is an independent predictor of incident major coronary heart disease events: results from the Framingham Heart Study. Circ Cardiovasc Imaging, 10, 2017, e006592.
61. Okwuosa, T.M., Greenland, P., Ning, H., Liu, K., Lloyd-Jones, D.M., Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. J Am Coll Cardiol Img 5 (2012), 923–930.
62. Rozanski, A., Berman, D.S., Use of coronary artery calcium scanning to screen for coronary atherosclerosis among early middle-age adults. J Am Coll Cardiol Img 5 (2012), 931–934.
63. Carr, J.J., Jacobs, D.R. Jr., Terry, J.G., et al. Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death. JAMA Cardiol 2 (2017), 391–399.
64. Shah, R.V., Spahillari, A., Mwasongwe, S., et al. Subclinical atherosclerosis, statin eligibility, and outcomes in African American individuals: the Jackson Heart Study. JAMA Cardiol 2 (2017), 644–652.
65. Sung, J.H., Yeboah, J., Lee, J.E., et al. Diagnostic value of coronary artery calcium score for cardiovascular disease in African Americans: the Jackson Heart Study. Br J Med Med Res, 11, 2016 BJMMR/2016/21449.
66. Manson, J.E., Allison, M.A., Carr, J.J., et al. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause 17 (2010), 683–691.
67. Wilson, P.W., Castelli, W.P., Kannel, W.B., Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 59:suppl (1987), 91G–94G.
68. JBS3 Board. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 100:suppl 2 (2014), ii1–67.
69. Anderson, T.J., Gregoire, J., Pearson, G.J., et al. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 32 (2016), 1263–1282.
70. McClelland, R.L., Jorgensen, N.W., Budoff, M., et al. 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study). J Am Coll Cardiol 66 (2015), 1643–1653.
71. MESA. MESA 10-year CHD risk with coronary artery calcification. Collaborative Health Studies Coordinating Center. Available at: https://www.mesa-nhlbi.org/MESACHDRisk/MesaRiskScore/RiskScore.aspx Accessed May 23, 2018.
72. Ambale-Venkatesh, B., Yang, X., Wu, C.O., et al. Cardiovascular event prediction by machine learning: the Multi-Ethnic Study of Atherosclerosis. Circ Res 121 (2017), 1092–1101.
73. Stone, N.J., Robinson, J.G., Lichtenstein, A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. [Published corrections appear in: J Am Coll Cardiol 2015;6:2812 and J Am Coll Cardiol 2014;63:3024–5] J Am Coll Cardiol 63 (2014), 2889–2934.
74. Kronmal, R.A., McClelland, R.L., Detrano, R., et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 115 (2007), 2722–2730.
75. Erbel, R., Lehmann, N., Churzidse, S., et al. Heinz Nixdorf Recall Study Investigators. Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J 35 (2014), 2960–2971.
76. Lehmann, N., Möhlenkamp, S., Mahabadi, A.A., et al. Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study. Atherosclerosis 232 (2014), 339–345.
77. Raggi, P., Callister, T.Q., Shaw, L.J., Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 24 (2004), 1272–1277.
78. Budoff, M.J., Young, R., Lopez, V.A., et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 61 (2013), 1231–1239.
79. Budoff, M.J., Hokanson, J.E., Nasir, K., et al. Progression of coronary artery calcium predicts all-cause mortality. J Am Coll Cardiol Img 3 (2010), 1229–1236.
80. McEvoy, J.W., Blaha, M.J., Defilippis, A.P., et al. Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol 56 (2010), 1613–1622.
81. Paixao, A.R., Chakravorty, R., Khera, A., et al. Disagreement between different definitions of coronary artery calcium progression. J Am Coll Cardiol Img 8 (2015), 743–744.
82. Lehmann, N., Erbel, R., Mahabadi, A.A., et al. Accelerated progression of coronary artery calcification in hypertension but also prehypertension. J Hypertens 34 (2016), 2233–2242.
83. Yeboah, J., McClelland, R.L., Polonsky, T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308 (2012), 788–795.
84. Möhlenkamp, S., Lehmann, N., Moebus, S., et al., for the Heinz Nixdorf Recall Study Investigators. Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J Am Coll Cardiol 57 (2011), 1455–1464.
85. Kianoush, S., Mirbolouk, M., Makam, R.C., Nasir, K., Blaha, M.J., Coronary artery calcium scoring in current clinical practice: how to define its value?. Curr Treat Options Cardiovasc Med, 19, 2017, 85.
86. Blaha, M.J., Budoff, M.J., DeFilippis, A.P., et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 378 (2011), 684–692.
87. Mortensen, M.B., Falk, E., Li, D., et al. Statin trials, cardiovascular events, and coronary artery calcification: implications for a trial-based approach to statin therapy in MESA. J Am Coll Cardiol Img 11 (2018), 221–230.
88. Mortensen, M.B., Fuster, V., Muntendam, P., et al. A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study. J Am Coll Cardiol 68 (2016), 881–891.
89. Martin, S.S., Blaha, M.J., Blankstein, R., et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the Multi-Ethnic Study of Atherosclerosis. Circulation 129 (2014), 77–86.
90. Nasir, K., Bittencourt, M.S., Blaha, M.J., et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 66 (2015), 1657–1668.
91. Hecht, H., Blaha, M.J., Berman, D.S., et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr 11 (2017), 157–168.
92. Mahabadi, A.A., Möhlenkamp, S., Lehmann, N., et al. CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines. J Am Coll Cardiol Img 10 (2017), 143–153.
93. Blaha, M.J., Cainzos-Achirica, M., Greenland, P., et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 133 (2016), 849–858.
94. Miedema, M.D., Duprez, D.A., Misialek, J.R., et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Qual Outcomes 7 (2014), 453–460.
95. Blaha, M.J., Personalizing treatment: between primary and secondary prevention. Am J Cardiol 118:suppl (2016), 4A–12A.
96. McEvoy, J.W., Martin, S.S., Dardari, Z.A., et al. Coronary artery calcium to guide a personalized risk-based approach to initiation and intensification of antihypertensive therapy. Circulation 135 (2017), 153–165.
97. Rozanski, A., Gransar, H., Shaw, L.J., et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 57 (2011), 1622–1632.
98. Shaw, L.J., Min, J.K., Budoff, M., et al. Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study. J Am Coll Cardiol 54 (2009), 1258–1267.
99. Nasir, K., McClelland, R.L., Blumenthal, R.S., et al. Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: the Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes 3 (2010), 228–235.
100. Gupta, A., Lau, E., Varshney, R., et al. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. J Am Coll Cardiol Img 10 (2017), 833–842.
101. Xie, X., Zhao, Y., de Bock, G.H., et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ Cardiovasc Imaging 6 (2013), 514–521.
102. Azour, L., Kadoch, M.A., Ward, T.J., Eber, C.D., Jacobi, A.H., Estimation of cardiovascular risk on routine chest CT: ordinal coronary artery calcium scoring as an accurate predictor of Agatston score ranges. J Cardiovasc Comput Tomogr 11 (2017), 8–15.
103. Blair, K.J., Allison, M.A., Morgan, C., et al. Comparison of ordinal versus Agatston coronary calcification scoring for cardiovascular disease mortality in community-living individuals. Int J Cardiovasc Imaging 30 (2014), 813–818.
104. Leigh, A.M.J., Garg, P., Carr, J., et al. Coronary artery calcium scores and atherosclerotic cardiovascular disease risk stratification in smokers: MESA. J Am Coll Cardiol Img, 2018 Feb 9 [E-pub ahead of print].
105. Berman, D.S., Wong, N.D., Gransar, H., et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 44 (2004), 923–930.
106. Chang, S.M., Nabi, F., Xu, J., et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol 54 (2009), 1872–1882.
107. Engbers, E.M., Timmer, J.R., Ottervanger, J.P., Mouden, M., Knollema, S., Jager, P.L., Prognostic value of coronary artery calcium scoring in addition to single-photon emission computed tomographic myocardial perfusion imaging in symptomatic patients. Circ Cardiovasc Imaging, 9, 2016, e003966.
108. Uretsky, S., Cohen, R., Argulian, E., et al. Combining stress-only myocardial perfusion imaging with coronary calcium scanning as a new paradigm for initial patient work-up: an exploratory analysis. J Nucl Cardiol 22 (2015), 89–97.
109. Bybee, K.A., Lee, J., Markiewicz, R., et al. Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging. J Nucl Cardiol 17 (2010), 188–196.
110. Alluri, K., Joshi, P.H., Henry, T.S., Blumenthal, R.S., Nasir, K., Blaha, M.J., Scoring of coronary artery calcium scans: history, assumptions, current limitations, and future directions. Atherosclerosis 239 (2015), 109–117.
111. Criqui, M.H., Denenberg, J.O., Ix, J.H., et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311 (2014), 271–278.
112. Blaha, M.J., Budoff, M.J., Tota-Maharaj, R., et al. Improving the CAC score by addition of regional measures of calcium distribution: Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol Img 9 (2016), 1407–1416.
113. Tota-Maharaj, R., Joshi, P.H., Budoff, M.J., et al. Usefulness of regional distribution of coronary artery calcium to improve the prediction of all-cause mortality. Am J Cardiol 115 (2015), 1229–1234.
114. Baron, K.B., Choi, A.D., Chen, M.Y., Low radiation dose calcium scoring: evidence and techniques. Curr Cardiovasc Imaging Rep, 9, 2016, 12.
115. Urabe, Y., Yamamoto, H., Kitagawa, T., et al. Identifying small coronary calcification in non-contrast 0.5-mm slice reconstruction to diagnose coronary artery disease in patients with a conventional zero coronary artery calcium score. J Atheroscler Thromb 23 (2016), 1324–1333.
116. Blaha, M.J., Mortensen, M.B., Kianoush, S., Tota-Maharaj, R., Cainzos-Achirica, M., Coronary artery calcium scoring: is it time for a change in methodology?. J Am Coll Cardiol Img 10 (2017), 923–937.
117. Tison, G.H., Guo, M., Blaha, M.J., et al. Multisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr 9 (2015), 406–414.
118. Blaha, M.J., Silverman, M.G., Budoff, M.J., Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients. Circ Cardiovasc Imaging 7 (2014), 398–408.
119. Handy, C.E., Desai, C.S., Dardari, Z.A., et al. The association of coronary artery calcium with noncardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol Img 9 (2016), 568–576.
120. Fujiyoshi, A., Jacobs, D.R. Jr., Fitzpatrick, A.L., et al. Coronary artery calcium and risk of dementia in MESA (Multi-Ethnic Study of Atherosclerosis). Circ Cardiovasc Imaging, 10, 2017, e005349.
121. Blaha, M.J., Whelton, S.P., Al Rifai, M., et al. Rationale and design of the Coronary Artery Calcium Consortium: a multicenter cohort study. J Cardiovasc Comput Tomogr 11 (2017), 54–61.
122. Whelton, S.P., Silverman, M.G., McEvoy, J.W., et al. Predictors of long-term healthy arterial aging: coronary artery calcium nondevelopment in the MESA study. J Am Coll Cardiol Img 8 (2015), 1393–1400.
123. U.S. Preventive Services Task Force. Draft recommendation statement: cardiovascular disease: risk assessment with nontraditional risk factors. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/coronary-heart-disease-screening-using-non-traditional-risk-assessment Accessed May 23, 2018.
124. Pender, A., Lloyd-Jones, D.M., Stone, N.J., Greenland, P., Refining statin prescribing in lower-risk individuals: informing risk/benefit decisions. J Am Coll Cardiol 68 (2016), 1690–1697.
125. O'Donnell, C.J., Kavousi, M., Smith, A.V., et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 124 (2011), 2855–2864.